Insider · CIK 0001008317

FRIEDLI PETER

Reports to the SEC for 3 companies · COLUMBIA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001008317

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-04-17	OSIRIS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,750 sh	$19.00	−$52.3K	0
2019-04-17	OSIRIS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−500K sh	$19.00	−$9.5M	0
2019-04-17	OSIRIS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−4.1M sh	$19.00	−$78M	0
2019-04-17	OSIRIS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−10.2M sh	$19.00	−$194M	0
2014-02-06	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$14.93	+$149K	10,204,404
2014-01-17	OSIRIS THERAPEUTICS, INC.J Other	Director	JOther	0 sh	—	—	4,606,051
2013-08-14	OSIRIS THERAPEUTICS, INC.Common Stock Purchase WarrantM Exercise/Conversion	Director	MExercise/Conversion	−1M sh	—	—	0
2013-08-14	OSIRIS THERAPEUTICS, INC.F Tax Payment	Director	FTax Payment	−432K sh	$25.44	−$11M	10,194,404
2013-08-14	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1M sh	$11.00	+$11M	10,626,794
2013-02-12	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$7.73	+$77.3K	9,626,794
2012-12-10	OSIRIS THERAPEUTICS, INC.S Sale	Director	SSale	−50K sh	$9.52	−$476K	4,606,051
2012-11-15	OSIRIS THERAPEUTICS, INC.S Sale	Director	SSale	−625 sh	$9.34	−$5,837.5	4,656,051
2012-03-23	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$5.08	+$50.8K	9,616,794
2011-12-06	OSIRIS THERAPEUTICS, INC.G Gift	Director	GGift	−500K sh	$4.87	−$2.44M	9,606,794
2011-02-14	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$7.13	+$71.3K	10,106,794
2009-02-23	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$18.60	+$186K	4,166,685
2008-03-24	OSIRIS THERAPEUTICS, INC.Convertible Promissory NoteP Purchase	Director	PPurchase	+2.5M sh	$12.17	+$30.4M	1,205,423
2008-02-04	OSIRIS THERAPEUTICS, INC.J Other	Director	JOther	+29.7K sh	—	—	9,870,371
2008-02-04	OSIRIS THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	$12.01	+$120K	4,974,245
2008-02-04	OSIRIS THERAPEUTICS, INC.G Gift	Director	GGift	−1,000 sh	$12.01	−$12K	9,841,630
2007-12-19	OSIRIS THERAPEUTICS, INC.Promissory NoteM Exercise/Conversion	Director	MExercise/Conversion	−472K sh	$13.00	−$6.14M	1,000,000
2007-12-19	OSIRIS THERAPEUTICS, INC.P Purchase	Director	PPurchase	+663K sh	$13.00	+$8.62M	9,837,630
2007-12-19	OSIRIS THERAPEUTICS, INC.P Purchase	Director	PPurchase	+100K sh	$12.37	+$1.24M	9,174,884
2007-06-06	OSIRIS THERAPEUTICS, INC.Convertible Promissory NoteP Purchase	Director	PPurchase	+4M sh	$18.00	+$72M	1,472,222
2007-06-06	OSIRIS THERAPEUTICS, INC.P Purchase	Director	PPurchase	+1.23M sh	$11.38	+$14M	9,074,884
2007-05-11	OSIRIS THERAPEUTICS, INC.J Other	Director	JOther	+37.4K sh	—	—	7,844,655
2005-06-24	INVENDA CORPSeries C Preferred StockP Purchase	Director, 10% Owner, Member of 13(d) Group	PPurchase	+125K sh	$4.00	+$500K	3,239,986
2005-04-26	INVENDA CORPSeries C Preferred StockP Purchase	Director, 10% Owner, Member of 13(d) Group	PPurchase	+250K sh	$4.00	+$1M	3,114,986
2005-04-19	INVENDA CORPSeries C Preferred StockP Purchase	Director, 10% Owner, Member of 13(d) Group	PPurchase	+125K sh	$4.00	+$500K	2,864,986
2005-02-22	INVENDA CORPA Award	Director, 10% Owner, Member of 13(d) Group	AAward	+100K sh	—	—	29,432,861
2004-08-03	VANTAGEMED CORPOption to purchase VantageMed common stockA Award	Director, 10% Owner	AAward	+20K sh	$0.60	+$12K	146,000
2003-09-22	VANTAGEMED CORPoption to purchase common stockA Award	Director, 10% Owner	AAward	+20K sh	$0.21	+$4,200	126,000

Recent filings

Accepted (ET)
Apr 174
FRIEDLI PETER0001104659-19-021852
SEC(opens sec.gov)
Feb 74
OSIRIS THERAPEUTICS, INC.0001179110-14-002273
SEC(opens sec.gov)
Jan 214
OSIRIS THERAPEUTICS, INC.0001179110-14-001159
SEC(opens sec.gov)
Aug 164
OSIRIS THERAPEUTICS, INC.0001179110-13-013263
SEC(opens sec.gov)
Feb 134
FRIEDLI PETER0001179110-13-002633
SEC(opens sec.gov)
Dec 104
FRIEDLI PETER0001179110-12-017200
SEC(opens sec.gov)
Nov 164
FRIEDLI PETER0001179110-12-016126
SEC(opens sec.gov)
Mar 274
FRIEDLI PETER0001179110-12-005791
SEC(opens sec.gov)
Dec 74
FRIEDLI PETER0001179110-11-016155
SEC(opens sec.gov)
Feb 164
FRIEDLI PETER0001179110-11-002832
SEC(opens sec.gov)
Feb 254
FRIEDLI PETER0001179110-09-003472
SEC(opens sec.gov)
Mar 264
FRIEDLI PETER0001179110-08-006590
SEC(opens sec.gov)
Feb 64
OSIRIS THERAPEUTICS, INC.0001179110-08-002541
SEC(opens sec.gov)

Companies

Address

C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046